Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990 Oct;65(4):260-2.

Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children

G DeStefano  1 , S Bonetti, C Bonizzato, E A Valletta, G L Piacentini, A L Boner
Affiliations
  • PMID: 2145790
Clinical Trial

Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children

G DeStefano et al. Ann Allergy. 1990 Oct.

Abstract

Inhaled albuterol (A) (salbutamol) alone and albuterol plus ipratropium bromide (IB) were administered to 12 asthmatic children. Following administration of A alone or in combination with IB, there was a significant increase in FEV1 and FEF. Significant statistical difference in favor of the association A plus IB was observed at 120 and 240 minutes for FEV1 and in the period 120, 180, and 240 minutes for FEF. The additive effect was present both in the large and small airways. The short-lived additive effect of A plus IB suggests the opportunity to increase the frequency of drug administration in patients with severe bronchial obstruction.

PubMed Disclaimer

Publication types